JPMorgan plans contingent interest autocallables tied to three stocks

By Susanna Moon

Chicago, Jan. 12 – JPMorgan Chase Financial Co. LLC plans to price autocallable contingent interest notes due Jan. 28, 2020 linked to the lesser performing of the common stocks of Celgene Corp., Amgen Inc. and Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by JPMorgan Chase & Co.

The notes will pay a contingent monthly coupon at an annual rate of at least 10% if each stock closes at or above its coupon barrier level, 57% of its initial level, on the review date for that month.

The notes will be called at par if each stock closes at or above its initial level on any autocall review date other than the first, second and final dates.

The payout at maturity will be par unless any stock finishes below its 57% trigger level, in which case investors will be fully exposed to any losses of the worst performing stock.

J.P. Morgan Securities LLC is the agent.

The notes will price on Jan. 23 and settle on Jan. 26.

The Cusip number is 46646QKA2.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.